The following definitions of frequencies are used: Common (≥ 1/100), Uncommon (≥ 1/1000, < 1/100), Rare (≥ 1/10,000, < 1/1,000), Very rare (≤ 1/10,000).
The following adverse drug reactions have been identified or suspected in the clinical trials programme for esomeprazole and/or from post-marketing use. None was found to be dose-related. (See table.)